Details

Autor(en) / Beteiligte

• Hu, Yue
• Pan, Xiaoting
• Nie, Mengjun
• Liu, Yuanjie
• Zou, Xi
• Liu, Shenlin
• Liu, Qin
• Wang, Ruiping
• Zhang, Li

Titel

A clinical study of Yiqi Huayu Jiedu decoction reducing the risk of postoperative gastric cancer recurrence and metastasis: Study protocol for a randomized controlled trail

Ist Teil von

• Medicine (Baltimore), 2020-08, Vol.99 (33), p.e21775-e21775

Ort / Verlag

United States: Lippincott Williams & Wilkins

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• Gastric cancer is a common gastrointestinal tumor, seriously threatening human health. Radical surgery is the preferred treatment for gastric cancer. However, due to the late diagnosis and postoperative recurrence and metastasis, the prognosis is dismal. In China, traditional Chinese medicine (TCM) has been used to treat gastric cancer for many years. The purpose of this study is to explore the efficacy and safety of Yiqi Huayu Jiedu decoction in the treatment of postoperative gastric caner. 226 eligibility patients altogether will be randomly allocated to the treatment group and the control group at a ratio of 1:1. After enrollment, every patients will obtain 6 months of treatment, as well as 2 years of follow-up. At the end of this study, primary outcomes including 1-year progression-free survival rate, 2-year progression-free survival rate and disease-free survival, secondary outcomes containing tumor markers, TCM syndrome points, quality of life scale, imageological examination and the safety indicators will be assessed. This study will provide the evidence-based evidence for the efficacy of Yiqi Huayu Jiedu decoction reducing the risk of postoperative gastric cancer recurrence and metastasis, which will be beneficial to form the therapeutic regimen in postoperative gastric cancer with integrated TCM and Western medicine. ChiCTR2000032802.